Technical report: Exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans

Invertebrate Neuroscience

Volumn 10, Issue 1, 2010, Pages 17-23

  Kaas, Bonnie ^a   Vaidya, Avinash R ^b   Leatherman, Amanda ^c   Schleidt, Stephanie ^b   Kohn, Rebecca Eustance ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b URSINUS COLLEGE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF LAW   (United States)

Author keywords

Acetylcholinesterase; Caenorhabditis elegans; Congenital myasthenic syndromes; Nicotinic acetylcholine receptor; Undergraduate

Indexed keywords

CAENORHABDITIS ELEGANS PROTEIN; CHOLINESTERASE INHIBITOR; NICOTINIC RECEPTOR; PYRIDOSTIGMINE; UNC 63 PROTEIN, C ELEGANS; UNC-63 PROTEIN, C ELEGANS;

ANIMAL; ARTICLE; CAENORHABDITIS ELEGANS; CONGENITAL MYASTHENIC SYNDROME; DISEASE MODEL; GENETICS; MEDICAL EDUCATION; METABOLISM; METHODOLOGY; MUTATION;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; EDUCATION, MEDICAL, UNDERGRADUATE; MUTATION; MYASTHENIC SYNDROMES, CONGENITAL; PYRIDOSTIGMINE BROMIDE; RECEPTORS, NICOTINIC;

EID: 78951493034     PISSN: 13542516     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10158-010-0101-2     Document Type: Article

References (32)

1. Baraka A, Mansour A, Haddad W, Wakid N (1981) Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity. Br J Anaesth 53:849-851 (Pubitemid 11044346)
2. Bieri T, Blasiar D, Ozersky P, Antoshechkin I, Bastiani C, Canaran P, Chan J, Chen N, Chen WJ, Davis P, Fiedler TJ, Girard L, Han M, Harris TW, Kishore R, Lee R, McKay S, Müller HM, Nakamura C, Petcherski A, Rangarajan A, Rogers A, Schindelman G, Schwarz EM, Spooner W, Tuli MA, Auken KV, Wang D, Wang X, Williams G, Durbin R, Stein LD, Sternberg PW, Spieth J (2007) Wormbase: new content and better access. Nucleic Acids Res 35:D506-D510 (Pubitemid 46056260)
3. Boulin T, Gielen M, Richmond JE, Williams DC, Paoletti P, Bessereau J-L (2008) Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor. Proc Natl Acad Sci 105(47):18590-18595
4. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van der Oost J, Smit AB, Sixma TK (2001) Crystal structure of an ACh-binding protein reveals the ligand binding domain of nicotinic receptors. Nature 411:269-276 (Pubitemid 32467026)
5. Brenner S (1974) The Genetics of Caenorhabditis elegans. Genetics 77:71-94
6. Breyer-Pfaff U, Maier U, Brinkmann AM, Schumm F (1985) Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis. Clin Pharmacol Ther 37(5):495-501 (Pubitemid 15007274)
7. Breyer-Pfaff U, Schmezer A, Maier U, Brinkmann A, Schumm F (1990) Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry 53:502-506 (Pubitemid 20189586)
8. Brown LA, Jones AK, Buckingham SD, Mee CJ, Sattelle DB (2006) Contributions from Caenorhabditis elegans functional genetics to antiparasitic drug target identification and validation: nicotinic acetylcholine receptors, a case study. Int J Parasitol 36:617-624 (Pubitemid 43765719)
9. Cooper E, Couturier S, Ballivet M (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350:235-238 (Pubitemid 21912207)
10. Culletto E, Baylis HA, Richmond JE, Jones AK, Fleming JT, Squire MD, Lewis JA, Sattelle DB (2004) The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor a subunit. J. Biol. Chem. 279:42476-42483 (Pubitemid 39372131)
11. Dunckley T, Wu J, Zhao L, Lukas RJ (2003) Mutational analysis of roles for extracellular cysteine residues in the assembly and function of human a7-nicotinic acetylcholine receptors. Biochemistry 42:870-876 (Pubitemid 36159517)
12. Engel AG, Uchitel OD, Walls TJ, Nagel A, Harper CM, Bodensteiner J (1993) Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel. Ann Neurol 34:38-47 (Pubitemid 23188725)
13. Engel AG, Ohno K, Milone M, Wang H-L, Nakano S, Bouzat C, Pruitt JN, Hutchinson DO, Brengman JM, Bren N, Sieb JP, Sine SM (1996) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 5:1217-1227 (Pubitemid 26335838)
14. Green WN, Wanamaker CP (1997) The role of the cystine loop in acetylcholine receptor assembly. J Biol Chem 272:20945-20953 (Pubitemid 27355667)
15. Hutchinson DO, Walls TJ, Nakano S, Camp S, Taylor P, Harper CM, Groover RV, Peterson HA, Jamieson DG, Engel AG (1993) Congenital endplate acetylcholinesterase deficiency. Brain 116:633-653 (Pubitemid 23203642)
16. Jones AK, Sattelle DB (2004) Functional genomics of the nicotinic acetylcholine receptor gene family of the nematode, Caenorhabditis elegans. BioEssays 26:39-49 (Pubitemid 38095347)
17. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Bio 305:567-580 (Pubitemid 33032862)
18. Lewis JA, Wu CH, Berg H, Levine JH (1980) The genetics of levamisole resistance in Caenorhabditis elegans. Genetics 95:905-928 (Pubitemid 11128555)
19. Mirakhur RK, Lavery TD, Briggs LP, Clarke RSJ (1982) Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Can Anaesth Soc J 29:55-58 (Pubitemid 12213494)
20. Mora M, Lambert EH, Engel AG (1987) Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 37:206-214 (Pubitemid 17015492)
21. Nguyen M, Alfonso A, Johnson CD, Rand JB (1995) Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 140(2):527-535
22. Pascuzzo GJ, Akaike A, Maleque MA, Shaw KP, Aronstam RS, Rickett DL, Albuquerque EX (1984) The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptorionic channel complex I. Agonist, desensitizing, and binding properties. Mol Pharmacol 25:92-101 (Pubitemid 14223259)
23. Rand JB, Russell RL (1984) Choline acetyltransferase-deficient mutants of the nematode Caenorhabditis elegans. Genetics 106(2):227-248
24. Sattelle DB, Culetto E, Baylis H (2000) International Publication No.WO 00/75311 Al. World Intellectual Property Organization: International Bureau Schara U, Lochmuller H (2008) Therapeutic strategies in congenital myasthenic syndromes. Neurotheratpeutics 5:542-547
25. Shen XM, Deymeer F, Sine SM, Engel AG (2006) Slow-channel mutation in acetylcholine receptor αM4 domain and its efficient knockdown. Ann Neurol 60:128-136
26. Sine SM, Ohno K, Bouzat C, Auerbach A, Milone M, Pruitt JN, Engel AG (1995) Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15(1):229-239
27. Touroutine D, Fox RM, Von Stetina SE, Burdina A, Miller DM, Richmond JE (2005) acr-16 encodes an essential subunit of the levamisole-resistant receptor at the Caenorhabditis elegans neuromuscular junction. JBC 280:27013-27021 (Pubitemid 41040738)
28. Unwin N (2005) Refined structure of the nicotinic acetylcholine receptor at 4 A° resolution. J Mol Biol 346:967-989 (Pubitemid 40215523)
29. Unwin N, Miyazawa A, Li J, Fujiyoshi Y (2002) Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the alpha subunits. J Mol Biol 319:1165-1176 (Pubitemid 34729426)
30. Walls TJ, Engel AG, Nagel AS, Harper CM, Trasek VF (1993) Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann NY Acad Sci 37:206-214
31. Wang Z-Z, Hardy SF, Hall ZW (1996) The first transmembrane domains of truncated a and d subunits are required for heterodimer formation in vivo. JBC 271:27575-27584
32. Webster R, Brydson M, Croxen R, Newsom-Davis J, Vincent A, Beeson D (2004) Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome. Neurology 62:1090-1096 (Pubitemid 38456501)